Filing Flows › Caribou Biosciences (CRBU) › Stock forecast & fair value
Caribou Biosciences (CRBU) stock forecast and price target
Caribou Biosciences (CRBU) trades at $0.45. 4 analysts' median price target is $4.50 (+903%), from $1.00 to $13.00.
Caribou Biosciences' latest quarter
Caribou Biosciences, Q3 2026: revenue $1.6M (-27% year over year), net loss $26.6M, operating cash flow −$22.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CRBU stock?
The median of 4 analysts' 12-month targets is $4.50, +903% from $0.45; the range is $1.00 to $13.00. The average rating is none.
Does Caribou Biosciences usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is CRBU stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.